🔎 Trials Near Me

Beranda › Kanker Pankreas › Pennsylvania › Pittsburgh

Uji klinis Kanker Pankreas di Pittsburgh, PA

20 studi untuk Kanker Pankreas mencari peserta di lokasi sekitar Pittsburgh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Menerima pesertaFase 1
  • UPMC Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05372614

Distance-Based Exercise to Preserve Function and Prevent Disability

Menerima peserta
  • UPMC Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884

Pancreatic Cancer Detection Consortium

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • AHN Cancer Institute at Allegheny General Hospital, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06388967

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Menerima pesertaFase 3
  • UPMC Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Menerima pesertaFase 3
  • Investigative Site US056, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07522073

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Menerima pesertaFase 3
  • AGH Singer Research Institute, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07409272

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Menerima pesertaFase 1/2
  • Allegheny Health Network, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Menerima pesertaStudi observasional
  • University of Pittsburgh, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06271291

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Menerima pesertaStudi observasional
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Hingga usia 17 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06651580

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Menerima pesertaStudi observasional
  • Bryn Mawr Hospital, Bryn Mawr · 11 mi jauhnya
Usia 50 hingga 75 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT04239573

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Menerima pesertaFase 1/2
  • UPMC Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04172532

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Menerima pesertaFase 3
  • Allegheny General Hospital, Pittsburgh
  • West Penn Hospital, Pittsburgh
  • Jefferson Hospital, Jefferson Hills · 11 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06958328

Pancreatic Cancer Early Detection Consortium

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • University of Pittsburgh Medical Center (Upmc), Pittsburgh
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT04970056

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Menerima pesertaFase 1
  • UPMC Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jun 2026 · NCT04890613

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Menerima pesertaFase 2
  • Allegheny General Hospital, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Apr 2026 · NCT06850623

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Menerima pesertaStudi observasional
  • Allegheny Health Network, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT04075305

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Menerima pesertaFase 2
  • Ohio State University-Telemedicine, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT06906562

Pancreatic Adenocarcinoma Gene Environment Risk Study

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • University of Pittsburgh, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Nov 2025 · NCT00912717

The Cancer of the Pancreas Screening-5 CAPS5)Study

Menerima pesertaFase 3
  • University of Pittsburgh, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Okt 2025 · NCT02000089

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Menerima pesertaFase 1
  • UPMC Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Agu 2025 · NCT04429542

Uji klinis Kanker Pankreas di kota lain

Studi lain di Pittsburgh

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.